Melatonin, active oxygen species and neurological damage

Area of Science:

• Biochemistry and Molecular Biology
• Neuroscience
• Gerontology

Background:

• Oxidative stress, caused by molecular damage from oxygen, is implicated in aging and various diseases.
• Antioxidants, particularly melatonin, are gaining clinical interest for their protective roles.
• Melatonin exhibits both direct free radical scavenging and indirect antioxidant mechanisms.

Purpose of the Study:

• To review the multifaceted antioxidant actions of melatonin.
• To explore melatonin's potential in mitigating oxidative stress-related conditions, including neurodegeneration.
• To assess the clinical applicability of melatonin based on its efficacy and safety profile.

Main Methods:

• Review of existing literature on melatonin's antioxidant properties and effects.
• Analysis of melatonin's influence on prooxidative and antioxidative enzymes.
• Examination of melatonin's protective effects in animal models of neurodegeneration.

Main Results:

• Melatonin directly scavenges free radicals and indirectly modulates antioxidant enzyme activity.
• Pharmacological levels of melatonin inhibit nitric oxide synthase (NOS) and stimulate antioxidative enzymes.
• Melatonin prevents lipid peroxidation-induced membrane fluidity changes and shows neuroprotection in animal studies.

Conclusions:

• Melatonin possesses significant antioxidant and neuroprotective capabilities.
• Its low toxicity profile warrants consideration for human clinical trials.
• Melatonin may offer a promising therapeutic strategy against free radical-induced diseases and aging.